
  
    
      
        Introduction_NNP
        RA_NNP is_VBZ an_DT autoimmune_JJ disease_NN that_WDT is_VBZ characterized_VBN by_IN
        persistent_JJ local_JJ and_CC systemic_JJ inflammation_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._.
        Aggressive_NNP forms_NNS of_IN RA_NNP are_VBP thought_VBN to_TO be_VB driven_VBN by_IN
        T-_NNP lymphocyte_NN activity_NN ,_, leading_VBG to_TO the_DT rapid_JJ erosion_NN of_IN bone_NN
        and_CC cartilage_NN ._. Activated_NNP Tm_NNP are_VBP found_VBN in_IN the_DT perivascular_NN
        regions_NNS of_IN the_DT inflamed_JJ synovium_NN ,_, and_CC T_NN cells_NNS accumulate_VBP in_IN
        the_DT synovial_NN fluid_JJ [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN ._. It_PRP appears_VBZ that_DT memory_NN T_NN
        cells_NNS retain_VBP the_DT potential_NN to_TO traffic_NN through_IN the_DT synovium_NN
        and_CC lymphatics_NNS and_CC recirculate_NN in_IN the_DT blood_NN ,_, as_IN evidenced_VBN
        by_IN the_DT increased_VBN numbers_NNS of_IN activated_VBN memory_NN T_NN cells_NNS found_VBD
        in_IN the_DT blood_NN of_IN some_DT RA_NNP patients_NNS [_NN 6_CD ,_, 7_CD ,_, 8_CD ]_NN ._. It_PRP is_VBZ not_RB
        known_VBN ,_, however_RB ,_, whether_IN Tm_NNP migrate_VB into_IN the_DT synovium_NN and_CC
        undergo_VBP activation_NN and_CC further_JJ differentiation_NN ,_, or_CC whether_IN
        activation_NN occurs_VBZ in_IN regional_JJ lymph_NN nodes_NNS before_IN migration_NN
        into_IN the_DT inflammatory_JJ site_NN ._.
        
        In_IN vitro_NN studies_NNS [_NN 9_CD ,_, 10_CD ]_NN have_VBP
        demonstrated_VBN that_DT synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS proliferate_VBP poorly_RB
        and_CC produce_VB decreased_VBD levels_NNS of_IN IL-_NNP 2_CD in_IN response_NN to_TO mitogen_NN
        or_CC antigen_NN ,_, as_IN compared_VBN with_IN peripheral_JJ blood_NN T_NN cells_NNS from_IN
        healthy_JJ individuals_NNS or_CC RA_NNP patients_NNS ._. Although_IN such_JJ findings_NNS
        suggest_VBP that_DT synovial_NN T_NN cells_NNS might_MD be_VB partly_RB anergic_JJ ,_, more_RBR
        recent_JJ studies_NNS have_VBP indicated_VBN that_IN the_DT T_NN cells_NNS found_VBD in_IN the_DT
        RA_NNP synovium_NN were_VBD postactivated_JJ cells_NNS ._. Synovial_NNP T_NN cells_NNS were_VBD
        activated_VBN as_IN assessed_VBN by_IN expression_NN of_IN CD_NNP 40_CD ligand_NN /_NN CD_NNP 154_CD ,_,
        and_CC were_VBD also_RB efficient_JJ helpers_NNS for_IN B-_NNP cell_NN immunoglobulin_NN
        production_NN [_NN 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ]_NN ._. Previous_JJ studies_NNS in_IN animal_NN
        models_NNS [_NN 14_CD ,_, 15_CD ]_NN suggested_VBD that_IN a_DT balance_NN exists_VBZ between_IN
        immunoregulatory_NN IFN-γ-producing_NNP Th_NNP 1_CD cells_NNS and_CC
        IL-_NNP 4_CD -_: producing_VBG Th_NNP 2_CD cells_NNS ._. Dominance_NNP of_IN either_DT subset_NN can_MD
        result_VB in_IN a_DT chronic_JJ disease_NN state_NN ._. Moreover_RB ,_, induction_NN of_IN
        Th_NNP 2_CD cells_NNS in_IN a_DT Th_NNP 1_CD -_: mediated_JJ disease_NN model_NN of_IN
        collagen-induced_JJ arthritis_NN led_VBN to_TO amelioration_NN of_IN
        autoimmune_JJ disease_NN [_NN 16_CD ]_NN ._. Thus_RB ,_, it_PRP is_VBZ possible_JJ that_IN ,_, in_IN RA_NNP ,_,
        there_EX is_VBZ biased_VBN differentiation_NN of_IN IFN-γ-secreting_NNP
        proinflammatory_NN Th_NNP 1_CD CD_NNP 4_CD +_NN T_NN cells_NNS ,_, and_CC insufficient_JJ
        differentiation_NN of_IN immunoregulatory_NN IL-_NNP 4_CD -_: producing_VBG Th_NNP 2_CD
        cells_NNS ._.
        Human_JJ memory_NN T_NN cells_NNS acquire_VB the_DT ability_NN to_TO secrete_NN IL-_NNP 4_CD
        late_RB during_IN 
        in_IN vivo_NN differentiation_NN ._. Our_PRP$ previous_JJ
        studies_NNS and_CC work_NN by_IN others_NNS have_VBP demonstrated_VBN that_IN all_DT of_IN
        the_DT 
        in_IN vivo_NN differentiated_JJ IL-_NNP 4_CD -_: producing_VBG
        T_NN cells_NNS reside_VB within_IN the_DT mature_VBP memory_NN (_( CD_NNP 45_CD RO_NNP +_NN ,_, CD_NNP 27_CD -_: )_)
        subset_NN of_IN CD_NNP 4_CD +_NN T_NN cells_NNS [_NN 17_CD ,_, 18_CD ,_, 19_CD ]_NN ._. Thus_RB ,_, early_JJ memory_NN
        (_( CD_NNP 45_CD RO_NNP +_NN ,_, CD_NNP 27_CD +_NN )_) CD_NNP 4_CD +_NN T_NN cells_NNS cannot_NN secrete_NN IL-_NNP 4_CD after_IN a_DT
        brief_NN 
        in_IN vitro_NN stimulation_NN ._. Previous_JJ
        studies_NNS [_NN 17_CD ,_, 18_CD ]_NN suggested_VBD that_IN early_JJ memory_NN T_NN cells_NNS
        represent_VBP an_DT uncommitted_JJ precursor_NN population_NN ,_, from_IN which_WDT
        both_DT IL-_NNP 4_CD -_: producing_VBG and_CC IFN-γ-producing_NNP effector_NN cells_NNS can_MD
        be_VB generated_VBN ._. The_DT RA_NNP synovium_NN appears_VBZ to_TO contain_VB an_DT
        increased_VBN number_NN of_IN phenotypically_RB mature_VBP memory_NN T_NN cells_NNS as_IN
        compared_VBN with_IN the_DT blood_NN ._. However_RB ,_, the_DT majority_NN of_IN memory_NN T_NN
        cells_NNS found_VBD in_IN the_DT synovium_NN bear_NN the_DT phenotype_NN of_IN early_JJ Tm_NNP
        [_NN 7_CD ]_NN ._.
        Therefore_RB ,_, the_DT present_JJ study_NN was_VBD undertaken_VBN to_TO examine_VB
        the_DT cytokine_NN effector_NN status_NN of_IN synovial_NN memory_NN T_NN cells_NNS and_CC
        the_DT functional_JJ status_NN of_IN immature_NN memory_NN cell_NN precursors_NNS of_IN
        cytokine-producing_JJ effector_NN cells_NNS ._. For_IN these_DT experiments_NNS ,_,
        Tm_NNP were_VBD isolated_VBN from_IN the_DT blood_NN of_IN normal_JJ subjects_NNS ,_, and_CC
        from_IN RAPB_NNP ,_, RASF_NNP and_CC RAST_NNP ._. Intracellular_NNP cytokine_NN expression_NN
        was_VBD assessed_VBN by_IN flow_NN cytometry_NN immediately_RB after_IN isolation_NN
        and_CC a_DT brief_NN 
        in_IN vitro_NN stimulation_NN ,_, or_CC after_IN 
        in_IN vitro_NN priming_VBG designed_VBN to_TO generate_VB
        IL-_NNP 4_CD -_: producing_VBG effector_NN T_NN cells_NNS ._.
        The_DT results_NNS suggest_VBP that_IN a_DT deficiency_NN in_IN the_DT generation_NN
        of_IN adequate_JJ numbers_NNS of_IN regulatory_JJ IL-_NNP 4_CD -_: producing_VBG effector_NN
        cells_NNS in_IN the_DT synovium_NN might_MD be_VB a_DT contributing_VBG factor_NN to_TO the_DT
        perpetuation_NN of_IN chronic_JJ inflammation_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Antibodies_NNP and_CC reagents_NNS
          MAbs_NNP used_VBD included_VBD the_DT following_VBG :_: anti-_NN CD_NNP 3_CD (_( OKT_NNP 3_CD ;_:
          American_NNP Type_NNP Culture_NNP Collection_NNP ,_, Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_) ,_,
          anti-_NN CD_NNP 8_CD (_( OKT_NNP 8_CD ;_: American_NNP Type_NNP Culture_NNP Collection_NNP )_) ,_,
          anti-_NN CD_NNP 16_CD (_( B_NNP 73_CD ._. 1_LS ;_: generous_JJ gift_NN of_IN Dr_NNP G_NNP Trinchieri_NNP ,_, The_DT
          Wistar_NNP Institute_NNP ,_, Philadelphia_NNP ,_, PA_NNP ,_, USA_NNP )_) ,_, anti-_NN CD_NNP 19_CD
          (_( Dako_NNP ,_, Glostrup_NNP ,_, Denmark_NNP )_) ,_, anti-_NN CD_NNP 45_CD RO_NNP (_( UCHL_NNP 1_CD ;_: Dako_NNP )_) ,_, and_CC
          anti-_NN CD_NNP 45_CD RA_NNP (_( 2_CD H_NNP 4_CD ;_: gift_NN of_IN Dr_NNP C_NNP Morimoto_NNP ,_, Boston_NNP ,_, MA_NNP ,_, USA_NNP )_)
          [_NN 17_CD ,_, 18_CD ]_NN ._. Anti-_NNP CD_NNP 28_CD (_( 28_CD ._. 2_LS )_) ,_, Phycoerythrin_NNP (_( PE_NNP )_) -_: labeled_VBN
          anti-_NN IL-_NNP 2_CD ,_, PE-labeled_NNP anti-_NN IL-_NNP 4_CD ,_, and_CC fluorescein_NN
          isothiocyanate_NN (_( FITC_NNP )_) -_: labeled_VBN anti-_NN IFN-γ_NNP was_VBD from_IN
          Pharmingen_NNP (_( San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. FITC-labeled_NNP anti-_NN CD_NNP 3_CD ,_,
          and_CC PE-labeled_NNP or_CC Quantum_NNP red-labeled_JJ anti-_NN CD_NNP 4_CD was_VBD from_IN
          Sigma_NNP (_( St_NNP Louis_NNP ,_, MO_NNP ,_, USA_NNP )_) ._. Recombinant_NNP IL-_NNP 4_CD and_CC
          recombinant_JJ IL-_NNP 15_CD were_VBD from_IN R_NN &_CC D_NNP Systems_NNPS (_( Minneapolis_NNP ,_,
          MN_NNP ,_, USA_NNP )_) ._. Neutralizing_NNP antihuman_NN IFN-γ_NNP antibody_NN was_VBD from_IN
          Endogen_NNP (_( Cambridge_NNP ,_, MA_NNP ,_, USA_NNP )_) ._. Culture_NNP medium_NN contained_VBD
          RPMI_NNP 1640_CD with_IN penicillin_NN G_NNP (_( 200_CD U_NNP /_NN ml_NN )_) ,_, gentamicin_NN (_( 10_CD
          μg_NN /_NN ml_NN )_) ,_, L-_NNP glutamine_NN (_( 0_CD ._. 3_LS mg_NN /_NN ml_NN )_) ,_, and_CC 10_CD %_NN normal_JJ human_JJ
          serum_NN [_NN 17_CD ]_NN ._.
        
        
          Patients_NNS
          All_DT patients_NNS had_VBD an_DT established_VBN diagnosis_NN of_IN RA_NNP ,_, as_IN
          defined_VBN by_IN the_DT 1987_CD revised_VBN criteria_NNS of_IN the_DT American_NNP
          College_NNP of_IN Rheumatology_NNP for_IN the_DT classification_NN of_IN RA_NNP ._. All_DT
          patients_NNS had_VBD long-standing_JJ ,_, active_JJ RA_NNP ._. All_DT samples_NNS were_VBD
          obtained_VBN after_IN informed_VBN consent_NN ,_, as_IN approved_VBN by_IN the_DT UT_NNP
          Southwestern_NNP Institutional_NNP Review_NNP Board_NNP ._. The_DT data_NNS shown_VBN
          were_VBD obtained_VBN from_IN 14_CD RA_NNP patients_NNS (_( age_NN range_NN 29_CD -_: 78_CD
          years_NNS )_) ._. Matching_NNP blood_NN and_CC synovial_NN fluid_NN were_VBD obtained_VBN
          from_IN six_CD patients_NNS ._. Peripheral_NNP blood_NN alone_RB was_VBD obtained_VBN
          from_IN one_CD patient_NN and_CC synovial_NN fluid_JJ samples_NNS were_VBD obtained_VBN
          from_IN three_CD patients_NNS ._. Matching_NNP blood_NN and_CC synovial_NN tissue_NN
          samples_NNS were_VBD obtained_VBN from_IN three_CD patients_NNS at_IN the_DT time_NN of_IN
          surgery_NN ._. An_DT additional_JJ synovial_NN tissue_NN sample_NN was_VBD
          obtained_VBN from_IN one_CD patient_NN ._.
        
        
          Cell_NNP preparation_NN
          Mononuclear_NNP cells_NNS were_VBD isolated_VBN from_IN synovial_NN tissue_NN
          by_IN treating_VBG the_DT synovial_NN tissue_NN with_IN collagenase_NN briefly_NN
          at_IN 37_CD °_NN C_NNP with_IN constant_JJ shaking_VBG ._. The_DT cells_NNS were_VBD washed_VBN ,_,
          filtered_VBN through_IN nylon_NN mesh_NN ,_, and_CC briefly_NN adhered_VBD to_TO
          plastic_NN petri_NN dishes_NNS at_IN 37_CD °_NN C_NNP to_TO deplete_VB residual_JJ
          fibroblast_NN and_CC monocytes_NNS [_NN 7_CD ,_, 9_CD ]_NN ._. Mononuclear_NNP cells_NNS were_VBD
          obtained_VBN from_IN blood_NN or_CC synovial_NN samples_NNS of_IN RA_NNP patients_NNS ,_,
          or_CC sex-matched_JJ and_CC age-matched_JJ healthy_JJ adult_NN individuals_NNS
          by_IN ficoll_NN density_NN centrifugation_NN ._. Cells_NNP were_VBD washed_VBN and_CC
          incubated_JJ with_IN neuraminidase-treated_JJ sheep_NN red_JJ blood_NN
          cells_NNS ,_, and_CC purified_JJ by_IN negative_JJ selection_NN panning_VBG as_RB
          previously_RB described_VBD [_NN 17_CD ]_NN ._. The_DT cells_NNS were_VBD incubated_JJ with_IN
          anti-_NN CD_NNP 8_CD ,_, anti-_NN CD_NNP 19_CD ,_, B_NNP 73_CD ._. 1_LS ,_, and_CC 2_CD H_NNP 4_CD mAbs_NNS ._. After_IN panning_VBG ,_,
          the_DT recovered_VBD cells_NNS were_VBD routinely_RB greater_JJR than_IN 99_CD %_NN CD_NNP 3_CD
          +_NN ,_, 95_CD %_NN CD_NNP 4_CD +_NN ,_, and_CC 90_CD %_NN enriched_JJ for_IN CD_NNP 45_CD RO_NNP +_NN cells_NNS ._.
        
        
          Cell_NNP culture_NN
          T_NN cells_NNS were_VBD immediately_RB stimulated_VBN after_IN isolation_NN
          with_IN ionomycin_NN (_( 0_CD ._. 5_LS μM_NN ;_: Sigma_NNP )_) ,_, phytohemagglutinin_NN (_( 2_CD
          μg_NN /_NN ml_NN ;_: Wellcome_NNP Diagnostics_NNPS ,_, Greenville_NNP ,_, NC_NNP ,_, USA_NNP )_) ,_, and_CC
          phorbol_NN myristate_NN acetate_NN (_( 20_CD ng_NN /_NN ml_NN ;_: Sigma_NNP )_) in_IN the_DT
          presence_NN of_IN monensin_NN (_( 2_CD μM_NN ;_: Sigma_NNP )_) for_IN 6_CD h_NN and_CC were_VBD fixed_VBN
          in_IN paraformaldehyde_NN for_IN subsequent_JJ intracellular_NN cytokine_NN
          analysis_NN ._. In_IN some_DT experiments_NNS ,_, T_NN cells_NNS were_VBD primed_VBN for_IN 1_CD
          week_NN before_IN cytokine_NN analysis_NN [_NN 17_CD ]_NN ._. T_NN cells_NNS (_( 5_CD ×_NN 10_CD
          5_CD cells_NNS /_NN ml_NN )_) were_VBD cultured_JJ in_IN 96_CD -_: well_RB plates_NNS (_( Costar_NNP ,_,
          Cambridge_NNP ,_, MA_NNP ,_, USA_NNP )_) ._. Where_WRB indicated_VBD ,_, wells_NNS were_VBD coated_VBN
          with_IN anti-_NN CD_NNP 3_CD mAb_NN (_( OKT_NNP 3_LS )_) before_IN addition_NN of_IN T_NN cells_NNS ._.
          Medium_NNP contained_VBD 10_CD U_NNP /_NN ml_NN recombinant_JJ IL-_NNP 2_CD ,_, 5_CD ng_NN /_NN ml_NN
          recombinant_JJ IL-_NNP 15_CD ,_, 50_CD ng_NN /_NN ml_NN recombinant_JJ IL-_NNP 4_CD ,_, anti-_NN CD_NNP 28_CD
          mAb_NN (_( 0_CD ._. 5_LS μg_NN /_NN ml_NN )_) and_CC ,_, where_WRB indicated_VBD ,_, neutralizing_VBG
          anti-_NN IFN-γ_NNP antibody_NN (_( 5_CD μg_NN /_NN ml_NN )_) ._. After_IN 1_CD week_NN in_IN culture_NN
          the_DT cells_NNS were_VBD harvested_VBN and_CC counted_VBN ._. The_DT cells_NNS were_VBD
          washed_VBN ,_, and_CC incubated_JJ for_IN 60_CD h_NN in_IN medium_NN containing_VBG IL-_NNP 2_CD
          (_( 10_CD U_NNP /_NN ml_NN )_) and_CC IL-_NNP 15_CD (_( 5_CD ng_NN /_NN ml_NN )_) before_IN restimulation_NN ._. In_IN
          preliminary_JJ experiments_NNS the_DT presence_NN of_IN IL-_NNP 4_CD during_IN the_DT
          rest_NN phase_NN did_VBD not_RB increase_VB the_DT number_NN of_IN IL-_NNP 4_CD -_: producing_VBG
          cells_NNS detected_VBD on_IN subsequent_JJ restimulation_NN ._. Restimulation_NNP
          and_CC intracellular_NN cytokine_NN analysis_NN were_VBD carried_VBN out_IN as_IN
          described_VBN above_IN for_IN immediately_RB stimulated_VBN T_NN cells_NNS [_NN
          17_CD ]_NN ._.
        
        
          Flow_NNP cytometry_NN
          T_NN cells_NNS (_( 3_CD ×_NN 10_CD 5_LS )_) were_VBD stained_JJ with_IN saturating_VBG
          amounts_NNS of_IN directly_RB conjugated_JJ mAb_NN and_CC analyzed_VBD on_IN the_DT
          fluorescence-activated_JJ cell_NN sorter_NN (_( FACScan_NNP ;_: Becton_NNP
          Dickinson_NNP ,_, San_NNP Jose_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. For_IN intracellular_NN staining_VBG
          of_IN cytokines_NNS ,_, cells_NNS were_VBD stimulated_VBN as_IN described_VBN above_IN ._.
          The_DT cells_NNS were_VBD harvested_VBN ,_, washed_VBN ,_, fixed_VBN with_IN
          paraformaldehyde_NN ,_, perme-abilized_JJ with_IN saponin_NN ,_, and_CC
          blocked_VBD with_IN rodent_NN serum_NN ._. The_DT cells_NNS were_VBD stained_JJ with_IN
          directly_RB conjugated_JJ mAbs_NNS to_TO human_JJ cytokines_NNS (_( Pharmingen_NNP )_)
          and_CC analyzed_VBN by_IN flow_NN cytometry_NN [_NN 17_CD ]_NN ._. Stimulated_NNP cells_NNS
          that_WDT were_VBD stained_JJ with_IN irrelevant_JJ mAbs_NNS were_VBD used_VBN as_IN
          controls_NNS ._. Analysis_NNP was_VBD carried_VBN out_IN on_IN 10_CD 4_CD cells_NNS for_IN each_DT
          sample_NN ._.
        
        
          Statistical_NNP analysis_NN
          Statistically_NNP significant_JJ differences_NNS in_IN the_DT
          percentages_NNS of_IN cells_NNS that_WDT expressed_VBD each_DT cytokine_NN were_VBD
          determined_VBN using_VBG the_DT two-tailed_JJ Student_NNP 's_POS 
          t_NN -_: test_NN ,_, or_CC the_DT Mann-_NNP Whitney_NNP Rank_NNP
          Sum_NNP when_WRB appropriate_JJ ._. 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._.
        
      
      
        Results_NNS
        
          Enrichment_NNP of_IN IFN-gamma_NNP producers_NNS in_IN freshly_RB
          isolated_VBN RA_NNP synovial_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS
          Initial_JJ experiments_NNS delineated_JJ cytokine_NN production_NN by_IN
          freshly_RB isolated_VBN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS obtained_VBN from_IN
          matching_VBG samples_NNS of_IN RAPB_NNP and_CC RASF_NNP ._. A_DT representative_NN
          sample_NN is_VBZ shown_VBN in_IN Fig_NNP ._. 1_LS (_( RA_NNP patient_NN 1_LS )_) ._. The_DT majority_NN of_IN
          peripheral_JJ blood_NN T_NN cells_NNS from_IN RA_NNP patients_NNS secreted_JJ IL-_NNP 2_CD
          alone_RB ,_, whereas_IN fewer_JJR cells_NNS secreted_JJ IFN-γ_NNP alone_RB or_CC in_IN
          combination_NN with_IN IL-_NNP 2_CD ._. By_IN contrast_NN ,_, the_DT CD_NNP 4_CD +_NN T_NN cells_NNS
          isolated_VBN from_IN the_DT synovial_NN fluid_JJ demonstrated_VBD a_DT
          significant_JJ increase_NN in_IN the_DT percentage_NN of_IN cells_NNS that_WDT
          produced_VBD IFN-γ_NNP alone_RB or_CC in_IN combination_NN with_IN IL-_NNP 2_CD ,_, whereas_IN
          a_DT decrease_NN was_VBD observed_VBN in_IN the_DT percentage_NN of_IN cells_NNS that_IN
          secreted_JJ IL-_NNP 2_CD alone_RB ._. Few_JJ cells_NNS from_IN peripheral_JJ blood_NN or_CC
          synovial_NN fluid_JJ produced_VBN IL-_NNP 4_CD ._.
          Matching_NNP samples_NNS obtained_VBN from_IN the_DT peripheral_JJ blood_NN
          and_CC synovial_NN tissue_NN of_IN RA_NNP patients_NNS were_VBD also_RB assessed_VBN for_IN
          cytokine_NN expression_NN (_( Fig_NNP ._. 1_LS ;_: RA_NNP patient_NN 7_CD )_) ._. As_IN was_VBD
          observed_VBN in_IN the_DT synovial_NN fluid_JJ ,_, memory_NN T_NN cells_NNS isolated_VBN
          from_IN the_DT synovial_NN tissue_NN contained_VBD a_DT decreased_VBN percentage_NN
          of_IN IL-_NNP 2_CD -_: producing_VBG cells_NNS and_CC an_DT increased_VBN percentage_NN of_IN
          IFN-γ-producing_NNP cells_NNS ._. Thus_RB ,_, T_NN cells_NNS isolated_VBN from_IN the_DT
          rheumatoid_NN synovial_NN tissue_NN and_CC fluid_JJ demonstrated_VBD a_DT
          polarized_VBN Th_NNP 1_CD cytokine_NN profile_NN ._.
          As_IN a_DT control_NN ,_, the_DT cytokine_NN profiles_NNS of_IN Tm_NNP from_IN normal_JJ
          adult_NN volunteers_NNS were_VBD examined_VBN (_( Fig_NNP ._. 1_LS ;_: normal_JJ 1_LS )_) ._. As_IN
          observed_VBD for_IN blood_NN from_IN RA_NNP patients_NNS ,_, the_DT majority_NN of_IN
          cells_NNS produced_VBD IL-_NNP 2_CD alone_RB ,_, whereas_IN fewer_JJR cells_NNS produced_VBD
          the_DT combination_NN of_IN IL-_NNP 2_CD and_CC IFN-γ_NNP ._. Relatively_RB infrequent_JJ
          cells_NNS expressed_VBD a_DT highly_RB polarized_VBN phenotype_NN by_IN producing_VBG
          either_DT IFN-γ_NNP alone_RB or_CC IL-_NNP 4_CD alone_RB ._.
          A_DT compilation_NN of_IN the_DT frequency_NN of_IN cells_NNS that_WDT produced_VBD
          each_DT cytokine_NN from_IN a_DT number_NN of_IN donors_NNS is_VBZ shown_VBN in_IN Fig_NNP ._. 2_LS ._.
          After_IN a_DT brief_NN 
          in_IN vitro_NN stimulation_NN ,_, the_DT majority_NN
          of_IN Tm_NNP obtained_VBD from_IN normal_JJ donors_NNS (_( 
          n_NN =_SYM 11_CD )_) produced_VBN IL-_NNP 2_CD alone_RB (_( 75_CD ±_NN
          4_CD %_NN ;_: mean_VB ±_NN SEM_NNP )_) ._. Fewer_JJR cells_NNS produced_VBD the_DT combination_NN of_IN
          IL-_NNP 2_CD and_CC IFN-γ_NNP (_( 14_CD ±_NN 3_CD %_NN )_) ._. Relatively_RB infrequent_JJ cells_NNS
          expressed_VBD a_DT highly_RB polarized_VBN phenotype_NN by_IN producing_VBG
          either_DT IFN-γ_NNP (_( 6_CD ±_NN 1_CD %_NN )_) or_CC IL-_NNP 4_CD alone_RB (_( 4_CD ±_NN 1_CD %_NN )_) ._. Less_JJR than_IN
          1_CD %_NN of_IN the_DT cells_NNS produced_VBD the_DT combination_NN of_IN IFN-γ_NNP and_CC
          IL-_NNP 4_CD ._.
          Cytokine_NNP secretion_NN profiles_NNS of_IN freshly_RB isolated_VBN Tm_NNP
          obtained_VBD from_IN RAPB_NNP (_( 
          n_NN =_SYM 9_CD )_) also_RB demonstrated_VBN that_IN most_JJS
          secreted_JJ IL-_NNP 2_CD alone_RB (_( 75_CD ±_NN 3_CD %_NN )_) ,_, whereas_IN fewer_JJR cells_NNS
          produced_VBD IL-_NNP 2_CD in_IN combination_NN with_IN IFN-γ_NNP (_( 8_CD ±_NN 1_CD %_NN )_) ._. There_EX
          was_VBD no_DT significant_JJ difference_NN between_IN the_DT normal_JJ T_NN cells_NNS
          and_CC RA_NNP T_NN cells_NNS for_IN these_DT two_CD groups_NNS ._. Of_IN note_NN ,_, there_EX was_VBD a_DT
          significant_JJ (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) increase_NN in_IN the_DT
          percentage_NN of_IN cells_NNS that_IN secreted_JJ IFN-γ_NNP alone_RB compared_VBD
          with_IN normal_JJ cells_NNS (_( 11_CD ±_NN 2_CD %_NN versus_CC 6_CD ±_NN 1_CD %_NN )_) ,_, whereas_IN there_EX
          was_VBD no_DT difference_NN between_IN normal_JJ blood_NN and_CC RAPB_NNP in_IN the_DT
          number_NN of_IN cells_NNS that_IN secreted_JJ IL-_NNP 4_CD alone_RB (_( 4_CD ±_NN 1_CD %_NN )_) or_CC in_IN
          the_DT frequency_NN of_IN those_DT rare_JJ cells_NNS that_WDT produced_VBD the_DT
          combination_NN of_IN IL-_NNP 4_CD and_CC IFN-γ_NNP (_( 1_CD ±_NN 0_CD %_NN )_) ._.
          There_EX was_VBD a_DT significant_JJ decrease_NN in_IN the_DT number_NN of_IN
          cells_NNS isolated_VBN from_IN RASF_NNP (_( 
          n_NN =_SYM 8_CD )_) that_WDT produced_VBD IL-_NNP 2_CD alone_RB (_( 31_CD
          ±_NN 9_CD %_NN )_) when_WRB compared_VBN with_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) T_NN cells_NNS ._. Moreover_RB ,_, an_DT
          increase_NN was_VBD observed_VBN in_IN the_DT number_NN of_IN cells_NNS that_IN
          secreted_JJ the_DT combination_NN of_IN IL-_NNP 2_CD and_CC IFN-γ_NNP (_( 27_CD ±_NN 3_CD %_NN )_) ,_,
          which_WDT was_VBD significantly_RB greater_JJR than_IN the_DT percentage_NN of_IN
          the_DT same_JJ subset_NN in_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) ._. The_DT percentage_NN of_IN
          RASF_NNP cells_NNS that_WDT produced_VBD IFN-γ_NNP alone_RB (_( 41_CD ±_NN 8_CD %_NN )_) was_VBD also_RB
          significantly_RB increased_VBN over_IN the_DT percentage_NN of_IN such_JJ cells_NNS
          in_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 002_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 002_CD )_) T_NN cells_NNS ._.
          Significantly_RB fewer_JJR cells_NNS produced_VBD IL-_NNP 4_CD alone_RB (_( 1_CD ±_NN 0_CD %_NN )_) as_IN
          compared_VBN with_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) T_NN cells_NNS ,_, whereas_IN no_DT
          significant_JJ difference_NN was_VBD observed_VBN in_IN the_DT number_NN of_IN
          cells_NNS that_WDT produced_VBD the_DT combination_NN of_IN IL-_NNP 4_CD and_CC IFN-γ_NNP (_( 2_CD
          ±_NN 0_CD %_NN )_) ._.
          RAST_NNP Tm_NNP (_( 
          n_NN =_SYM 4_LS )_) also_RB contained_VBD a_DT decreased_VBN
          percentage_NN of_IN IL-_NNP 2_CD -_: secreting_VBG cells_NNS (_( 37_CD ±_NN 9_CD %_NN )_) ,_, which_WDT did_VBD
          not_RB differ_VB significantly_RB from_IN that_DT in_IN the_DT RASF_NNP ,_, but_CC did_VBD
          differ_VB significantly_RB from_IN that_DT in_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) and_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ._. The_DT percentage_NN of_IN
          cells_NNS that_WDT produced_VBD both_DT IFN-γ_NNP and_CC IL-_NNP 2_CD (_( 25_CD ±_NN 1_CD %_NN )_) did_VBD not_RB
          differ_VB significantly_RB from_IN that_DT in_IN RASF_NNP ,_, but_CC was_VBD
          significantly_RB greater_JJR than_IN the_DT frequencies_NNS observed_VBD in_IN
          normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) ._. In_IN RAST_NNP ,_, 34_CD ±_NN 9_CD %_NN of_IN
          cytokine_NN effectors_NNS secreted_JJ IFN-γ_NNP alone_RB ._. This_DT was_VBD not_RB
          different_JJ from_IN the_DT percentage_NN found_VBD in_IN RASF_NNP ,_, but_CC was_VBD
          significantly_RB greater_JJR than_IN the_DT percentage_NN of_IN
          IFN-γ-producing_NNP cells_NNS in_IN normal_JJ blood_NN (_( 
          P_NN <_NN 0_CD ._. 005_CD )_) or_CC RAPB_NNP (_( 
          P_NN <_NN 0_CD ._. 005_CD )_) ._. There_EX was_VBD no_DT
          significant_JJ difference_NN in_IN the_DT number_NN of_IN synovial_NN tissue_NN
          cells_NNS that_WDT produced_VBD IL-_NNP 4_CD alone_RB (_( 2_CD ±_NN 1_CD %_NN )_) or_CC IL-_NNP 4_CD and_CC IFN-γ_NNP
          (_( 2_CD ±_NN 0_CD %_NN )_) ,_, as_IN compared_VBN with_IN RASF_NNP ,_, normal_JJ blood_NN or_CC
          RAPB_NNP ._.
          Thus_RB ,_, T_NN cells_NNS isolated_VBN from_IN RAST_NNP and_CC RASF_NNP demonstrated_VBD
          a_DT decrease_NN in_IN IL-_NNP 2_CD -_: producing_VBG cells_NNS ,_, with_IN a_DT concomitant_NN
          increase_NN in_IN IFN-γ-producing_NNP cells_NNS when_WRB compared_VBN with_IN
          normal_JJ blood_NN and_CC RAPB_NNP Tm_NNP ._.
        
        
          Rheumatoid_NNP CD_NNP 4_CD +_NN T_NN cells_NNS demonstrate_VBP defective_JJ
          responsiveness_NNS to_TO differentiation_NN signals_NNS in_IN vitro_NN
          Peripheral_NNP blood_NN and_CC synovial_NN Tm_NNP were_VBD than_IN examined_VBD in_IN
          an_DT 
          in_IN vitro_NN culture_NN system_NN in_IN order_NN to_TO
          determine_VB the_DT relative_JJ capacity_NN of_IN differentiation_NN
          signals_NNS to_TO modulate_VBP cytokine_NN production_NN ._. Our_PRP$ previous_JJ
          studies_NNS with_IN normal_JJ T_NN cells_NNS [_NN 17_CD ]_NN demonstrated_VBN that_IN this_DT
          system_NN effectively_RB generates_VBZ polarized_VBN IFN-γ-producing_NNP or_CC
          IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS ._. Fig_NNP ._. 3_LS shows_VBZ the_DT composite_JJ
          cytokine_NN profiles_NNS of_IN CD_NNP 4_CD +_NN ,_, CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS obtained_VBN from_IN
          cultures_NNS primed_VBN with_IN anti-_NN CD_NNP 28_CD and_CC cytokines_NNS in_IN the_DT
          absence_NN or_CC presence_NN of_IN anti-_NN CD_NNP 3_CD mAb_NN ._. As_IN seen_VBN in_IN Fig_NNP ._. 3_LS ,_,
          stimulation_NN of_IN normal_JJ T_NN cells_NNS after_IN priming_VBG with_IN
          anti-_NN CD_NNP 28_CD alone_RB resulted_VBD in_IN a_DT significant_JJ decrease_NN in_IN the_DT
          percentage_NN of_IN IL-_NNP 2_CD producers_NNS (_( 35_CD %_NN versus_CC 75_CD %_NN )_) compared_VBN
          with_IN cells_NNS immediately_RB stimulated_VBN after_IN isolation_NN ,_, and_CC a_DT
          significant_JJ increase_NN in_IN the_DT percentages_NNS of_IN IFN-γ_NNP (_( 31_CD %_NN
          versus_CC 6_CD %_NN )_) and_CC IL-_NNP 4_CD producers_NNS (_( 17_CD %_NN versus_CC 4_CD %_NN )_) ._. After_IN
          priming_VBG with_IN a_DT low_JJ dose_NN of_IN anti-_NN CD_NNP 3_CD (_( Fig_NNP ._. 3_LS ;_: middle_JJ
          panel_NN )_) ,_, the_DT percentage_NN of_IN IL-_NNP 2_CD producers_NNS decreased_VBD
          further_JJ and_CC the_DT percentage_NN of_IN IFN-γ-secreting_NNP cells_NNS
          increased_VBN ._. As_IN previously_RB shown_VBN ,_, the_DT generation_NN of_IN
          IL-_NNP 4_CD -_: secreting_VBG cells_NNS was_VBD optimally_RB induced_VBN by_IN priming_VBG
          with_IN anti-_NN CD_NNP 28_CD alone_RB and_CC was_VBD inhibited_VBD by_IN costimulation_NN
          with_IN anti-_NN CD_NNP 3_CD mAb_NN [_NN 17_CD ]_NN ._.
          T_NN cells_NNS derived_VBN from_IN RAPB_NNP demonstrated_VBD a_DT distinct_JJ
          pattern_NN of_IN responsiveness_NNS ._. Whereas_IN the_DT percentage_NN of_IN
          IL-_NNP 2_CD -_: secreting_VBG cells_NNS decreased_VBD after_IN 
          in_IN vitro_NN priming_VBG with_IN anti-_NN CD_NNP 28_CD as_IN
          compared_VBN with_IN freshly_RB isolated_VBN cells_NNS (_( 52_CD %_NN versus_CC 75_CD %_NN )_) ,_, a_DT
          greater_JJR decrease_NN was_VBD observed_VBN after_IN priming_VBG with_IN low_JJ dose_NN
          anti-_NN CD_NNP 3_CD (_( 29_CD %_NN )_) ,_, and_CC the_DT cells_NNS were_VBD resistant_JJ to_TO further_VB
          modulation_NN by_IN higher_JJR concentrations_NNS of_IN anti-_NN CD_NNP 3_CD ._. Of_IN note_NN ,_,
          the_DT loss_NN of_IN IL-_NNP 2_CD production_NN by_IN 
          in_IN vitro_NN primed_VBN RA_NNP T_NN cells_NNS was_VBD less_JJR
          marked_VBD than_IN observed_VBD with_IN normal_JJ T_NN cells_NNS ._. An_DT increased_VBN
          percentage_NN of_IN IFN-γ_NNP producers_NNS was_VBD observed_VBN after_IN priming_VBG ,_,
          and_CC the_DT peak_NN response_NN was_VBD achieved_VBN in_IN the_DT presence_NN of_IN low_JJ
          concentrations_NNS of_IN anti-_NN CD_NNP 3_CD (_( 45_CD %_NN versus_CC 11_CD %_NN )_) ._. Again_RB ,_, the_DT
          induction_NN of_IN IFN-γ_NNP production_NN in_IN RAPB_NNP memory_NN T_NN cells_NNS was_VBD
          less_RBR than_IN noted_VBD in_IN normal_JJ blood_NN ._. IL-_NNP 4_CD -_: producing_VBG cells_NNS
          were_VBD generated_VBN from_IN RA_NNP memory_NN T_NN cells_NNS by_IN stimulation_NN with_IN
          anti-_NN CD_NNP 28_CD ,_, and_CC these_DT were_VBD inhibited_VBD by_IN the_DT presence_NN of_IN
          anti-_NN CD_NNP 3_CD mAb_NN ._. The_DT percentage_NN of_IN IL-_NNP 4_CD producers_NNS (_( 12_CD %_NN )_)
          generated_VBN from_IN RA_NNP memory_NN T_NN cells_NNS was_VBD less_RBR than_IN was_VBD
          generated_VBN from_IN normal_JJ T_NN cells_NNS (_( 17_CD %_NN )_) ._.
          T_NN cells_NNS from_IN RASF_NNP primed_VBN with_IN anti-_NN CD_NNP 28_CD exhibited_VBN a_DT
          decrease_NN in_IN the_DT percentage_NN of_IN IL-_NNP 2_CD -_: producing_VBG cells_NNS (_( 15_CD %_NN
          versus_CC 31_CD %_NN )_) and_CC an_DT increase_NN in_IN the_DT percentage_NN of_IN IFN-γ_NNP
          secreting_VBG cells_NNS (_( 67_CD %_NN versus_CC 41_CD %_NN )_) as_IN compared_VBN with_IN freshly_RB
          isolated_VBN cells_NNS ._. Synovial_NNP fluid_JJ T_NN cells_NNS were_VBD deficient_NN in_IN
          the_DT ability_NN to_TO generate_VB IL-_NNP 4_CD -_: producing_VBG cells_NNS (_( 1_CD %_NN )_) ,_, which_WDT
          was_VBD in_IN contrast_NN to_TO the_DT blood_NN ._. Whereas_IN RAPB_NNP T_NN cells_NNS were_VBD
          refractory_JJ to_TO priming_VBG by_IN high_JJ concentrations_NNS of_IN anti-_NN CD_NNP 3_CD
          mAb_NN ,_, the_DT synovial_NN fluid_JJ T_NN cells_NNS responded_VBD to_TO anti-_NN CD_NNP 3_CD in_IN
          a_DT dose-dependent_JJ manner_NN ._. T_NN cells_NNS derived_VBN from_IN synovial_NN
          tissue_NN were_VBD also_RB relatively_RB refractory_JJ to_TO 
          in_IN vitro_NN priming_VBG as_IN compared_VBN with_IN
          normal_JJ blood_NN T_NN cells_NNS ._. Synovial_NNP tissue_NN T_NN cells_NNS contained_VBD
          an_DT increased_VBN percentage_NN of_IN IL-_NNP 2_CD producers_NNS (_( 48_CD %_NN versus_CC
          37_CD %_NN )_) and_CC a_DT small_JJ decrease_NN in_IN IFN-γ_NNP producers_NNS (_( 23_CD %_NN versus_CC
          34_CD %_NN )_) after_IN 
          in_IN vitro_NN priming_VBG with_IN anti-_NN CD_NNP 28_CD ._.
          Importantly_NNP ,_, IL-_NNP 4_CD -_: secreting_VBG cells_NNS (_( 8_CD %_NN versus_CC 2_CD %_NN )_) could_MD be_VB
          generated_VBN from_IN synovial_NN tissue_NN memory_NN T_NN cells_NNS after_IN 
          in_IN vitro_NN differentiation_NN ,_, although_IN
          in_IN lesser_JJR numbers_NNS than_IN from_IN RAPB_NNP and_CC normal_JJ blood_NN ._.
          Priming_NNP in_IN the_DT presence_NN of_IN anti-_NN CD_NNP 3_CD reduced_VBD the_DT
          percentages_NNS of_IN IL-_NNP 2_CD -_: producing_VBG and_CC IL-_NNP 4_CD -_: producing_VBG cells_NNS ,_,
          while_IN increasing_VBG the_DT percentage_NN of_IN IFN-γ-secreting_NNP
          cells_NNS ._.
        
        
          Effect_NN of_IN anti-_NN IFN-gamma_NNP ;_: antibody_NN on_IN the_DT
          generation_NN of_IN IL-_NNP 4_CD -_: secreting_VBG effector_NN cells_NNS from_IN RA_NNP
          synovial_NN fluid_JJ T_NN cells_NNS
          In_IN order_NN to_TO determine_VB whether_IN cytokine_NN production_NN by_IN
          rheumatoid_NN T_NN cells_NNS was_VBD resistant_JJ to_TO modulation_NN in_IN the_DT 
          in_IN vitro_NN priming_VBG cultures_NNS because_IN
          of_IN the_DT secretion_NN of_IN IFN-γ_NNP ,_, the_DT 
          in_IN vitro_NN priming_VBG was_VBD also_RB carried_VBN
          out_IN in_IN the_DT presence_NN of_IN anti-_NN IFN-γ_NNP antibody_NN ._. As_IN shown_VBN in_IN
          Fig_NNP ._. 4_LS ,_, the_DT addition_NN of_IN increasing_VBG concentrations_NNS of_IN a_DT
          neutralizing_VBG antibody_NN to_TO IFN-γ_NNP had_VBD little_JJ effect_NN on_IN the_DT
          generation_NN of_IN cytokine-producing_JJ cells_NNS from_IN either_DT normal_JJ
          synovial_NN fluid_JJ or_CC RASF_NNP CD_NNP 4_CD +_NN T_NN cells_NNS ._. Then_RB we_PRP examined_VBD
          whether_IN the_DT combined_VBN effects_NNS of_IN anti-_NN IFN-γ_NNP antibody_NN and_CC
          IL-_NNP 4_CD could_MD influence_VB the_DT effector_NN phenotype_NN of_IN cells_NNS
          isolated_VBN from_IN the_DT synovium_NN ._. As_IN shown_VBN in_IN Table_NNP 1_CD ,_, Tm_NNP were_VBD
          isolated_VBN from_IN matching_VBG RAPB_NNP and_CC RASF_NNP ,_, and_CC were_VBD cultured_JJ
          under_IN conditions_NNS that_IN optimized_JJ the_DT generation_NN of_IN
          IL-_NNP 4_CD -_: secreting_VBG effector_NN cells_NNS [_NN 17_CD ]_NN ._. RAPB_NNP Tm_NNP generated_VBD a_DT
          marked_VBN increase_NN in_IN the_DT percentage_NN of_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS
          when_WRB primed_VBN with_IN the_DT combination_NN of_IN IL-_NNP 4_CD and_CC anti-_NN IFN-γ_NNP
          antibody_NN ._. In_IN contrast_NN ,_, T_NN cells_NNS from_IN the_DT synovial_NN fluid_NN of_IN
          the_DT same_JJ patient_NN generated_VBN virtually_RB no_DT IL-_NNP 4_CD -_: producing_VBG
          cells_NNS and_CC few_JJ IL-_NNP 2_CD -_: producing_VBG cells_NNS ,_, despite_IN supplemental_JJ
          IL-_NNP 4_CD and_CC anti-_NN IFN-γ_NNP antibody_NN ._.
          As_IN a_DT control_NN ,_, cell_NN growth_NN during_IN the_DT priming_VBG cultures_NNS
          was_VBD monitored_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN antibody_NN to_TO
          IFN-γ_NNP and_CC IL-_NNP 4_CD ._. As_IN shown_VBN in_IN Fig_NNP ._. 5_LS ,_, synovial_NN T-_NNP cell_NN
          growth_NN was_VBD not_RB inhibited_VBD by_IN the_DT addition_NN of_IN anti-_NN IFN-γ_NNP
          antibody_NN or_CC IL-_NNP 4_CD ._. These_DT data_NNS suggest_VBP that_IN RAPB_NNP Tm_NNP have_VBP
          the_DT capacity_NN to_TO generate_VB IL-_NNP 4_CD -_: producing_VBG or_CC
          IFN-γ-producing_NNP effector_NN cells_NNS ,_, whereas_IN memory_NN T_NN cells_NNS
          from_IN RASF_NNP are_VBP inhibited_VBD in_IN their_PRP$ capacity_NN to_TO become_VB
          IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS ._. Further_RB studies_VBZ indicated_VBD
          that_DT anti-_NN CD_NNP 28_CD mAb_NN and_CC cytokines_NNS enhanced_JJ synovial_NN fluid_JJ
          Tm_NNP growth_NN approximately_RB fourfold_NN above_IN the_DT initial_JJ input_NN
          cell_NN number_NN ._. Synovial_NNP fluid_JJ T_NN cells_NNS cultured_JJ in_IN medium_NN
          alone_RB underwent_VBD a_DT fourfold_NN reduction_NN in_IN cell_NN number_NN ,_,
          whereas_IN cells_NNS cultured_JJ with_IN cytokines_NNS alone_RB increased_VBN in_IN
          number_NN by_IN an_DT average_NN of_IN twofold_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT
          data_NNS further_JJ support_NN the_DT conclusion_NN that_DT synovial_NN fluid_JJ T_NN
          cells_NNS were_VBD responsive_JJ to_TO signals_NNS delivered_VBN by_IN the_DT
          combination_NN of_IN anti-_NN CD_NNP 28_CD and_CC cytokines_NNS ._.
        
      
      
        Discussion_NNP
        RAST_NNP and_CC RASF_NNP were_VBD deficient_NN in_IN IL-_NNP 4_CD -_: secreting_VBG cells_NNS as_IN
        compared_VBN with_IN RAPB_NNP after_IN a_DT brief_NN 
        in_IN vitro_NN stimulation_NN ._. Thus_RB ,_, mature_VBP
        IL-_NNP 4_CD -_: secreting_VBG effector_NN cells_NNS were_VBD found_VBN to_TO be_VB decreased_VBN in_IN
        the_DT RA_NNP synovium_NN but_CC not_RB in_IN the_DT blood_NN ._.
        There_RB are_VBP at_IN least_JJS three_CD major_JJ mechanisms_NNS by_IN which_WDT IL-_NNP 4_CD
        production_NN might_MD be_VB inhibited_VBD in_IN the_DT RA_NNP synovium_NN ._. One_CD
        mechanism_NN could_MD be_VB through_IN the_DT selective_JJ recruitment_NN of_IN
        IFN-γ-producing_NNP effector_NN cells_NNS ._. For_IN example_NN ,_, it_PRP has_VBZ been_VBN
        suggested_VBN that_IN the_DT T_NN cells_NNS found_VBD in_IN the_DT RA_NNP synovium_NN have_VBP
        been_VBN selectively_RB recruited_VBN on_IN the_DT basis_NN of_IN expression_NN of_IN
        chemokine_NN receptors_NNS [_NN 20_CD ]_NN ._. Thus_RB ,_, T_NN cells_NNS found_VBD in_IN the_DT
        rheumatoid_NN synovium_NN express_VB CCR_NNP 5_CD ,_, whereas_IN T_NN cells_NNS found_VBD at_IN
        sites_NNS of_IN parasitic_JJ infection_NN express_VB CCR_NNP 4_CD and_CC CCR_NNP 3_CD [_NN 20_CD ,_,
        21_CD ]_NN ._. However_RB ,_, the_DT role_NN of_IN chemokine_NN receptor_NN expression_NN in_IN
        the_DT recruitment_NN of_IN T_NN cells_NNS to_TO these_DT sites_NNS is_VBZ unknown_JJ ._. This_DT
        possibility_NN cannot_NN be_VBP the_DT full_JJ explanation_NN of_IN the_DT current_JJ
        observations_NNS in_IN light_NN of_IN the_DT finding_VBG that_DT synovial_NN tissue_NN T_NN
        cells_NNS had_VBD the_DT capacity_NN to_TO differentiate_VB into_IN IL-_NNP 4_CD -_: secreting_VBG
        effector_NN cells_NNS in_IN 
        in_IN vitro_NN cultures_NNS ._. Thus_RB ,_, some_DT
        synovial_NN cells_NNS remained_VBD responsive_JJ to_TO IL-_NNP 4_CD -_: and_CC
        anti-_NN CD_NNP 28_CD -_: mediated_JJ signaling_VBG in_IN the_DT priming_VBG cultures_NNS ._. A_DT
        second_JJ mechanism_NN for_IN suppression_NN of_IN IL-_NNP 4_CD production_NN in_IN the_DT
        rheumatoid_NN synovium_NN could_MD be_VB through_IN regulatory_JJ signals_NNS
        received_VBD in_IN the_DT local_JJ microenvironment_NN ._. This_DT remains_VBZ a_DT
        likely_JJ possibility_NN because_IN studies_NNS in_IN murine_NN models_NNS have_VBP
        shown_VBN that_IN only_RB the_DT most_RBS highly_RB differentiated_JJ T_NN cells_NNS
        obtain_VBP a_DT polarized_VBN cytokine_NN secretion_NN profile_NN that_DT cannot_NN
        be_VB altered_VBN by_IN external_JJ stimuli_NNS [_NN 22_CD ]_NN ._. A_DT third_JJ possibility_NN
        is_VBZ that_IN precursor_NN cells_NNS of_IN IL-_NNP 4_CD producers_NNS rapidly_RB migrate_VB
        out_IN of_IN the_DT synovium_NN ,_, perhaps_RB being_VBG unresponsive_JJ to_TO
        retention_NN signals_NNS ._.
        Although_IN the_DT exact_JJ mechanism_NN that_WDT is_VBZ operative_JJ in_IN the_DT RA_NNP
        synovium_NN remains_VBZ to_TO be_VB elucidated_JJ ,_, our_PRP$ ongoing_JJ studies_NNS are_VBP
        focused_VBN on_IN determining_VBG the_DT phenotype_NN and_CC response_NN defect_NN of_IN
        these_DT highly_RB polarized_VBN Th_NNP cells_NNS ._.
        Tm_NNP isolated_VBD from_IN rheumatoid_NN blood_NN or_CC synovium_NN contained_VBD
        increased_VBN numbers_NNS of_IN cells_NNS with_IN the_DT capacity_NN to_TO produce_VB
        IFN-γ_NNP after_IN a_DT brief_NN 
        in_IN vitro_NN stimulation_NN ,_, compared_VBN with_IN
        the_DT same_JJ subset_NN isolated_VBN from_IN the_DT periphery_NN of_IN normal_JJ
        donors_NNS ._. A_DT strong_JJ mitogenic_JJ stimulation_NN was_VBD employed_VBN in_IN
        order_NN to_TO obtain_VB the_DT maximum_NN cytokine-secreting_JJ potential_NN of_IN
        the_DT effector_NN population_NN ._. We_PRP have_VBP previously_RB demonstrated_VBN
        that_IN staining_VBG for_IN intracellular_NN cytokines_NNS correlated_JJ with_IN
        cytokine_NN secretion_NN [_NN 17_CD ]_NN ._. However_RB ,_, intracellular_NN cytokine_NN
        analysis_NN proved_VBD to_TO be_VB a_DT more_RBR sensitive_JJ method_NN for_IN detecting_VBG
        cytokines_NNS ,_, such_JJ as_IN IL-_NNP 2_CD and_CC IL-_NNP 4_CD ,_, and_CC also_RB made_VBN it_PRP possible_JJ
        to_TO determine_VB the_DT percentage_NN of_IN cells_NNS producing_VBG each_DT ._. It_PRP
        should_MD be_VB noted_VBN that_IN longer_JJR incubations_NNS did_VBD not_RB result_VB in_IN a_DT
        substantial_JJ increase_NN in_IN the_DT number_NN of_IN cytokine-secreting_JJ
        cells_NNS detected_VBD in_IN this_DT assay_NN ._. These_DT studies_NNS corroborate_VBP
        previous_JJ studies_NNS that_WDT demonstrated_VBD that_DT synovial_NN T_NN cells_NNS
        are_VBP enriched_JJ in_IN IFN-γ-producing_NNP cells_NNS on_IN initial_JJ isolation_NN
        [_NN 11_CD ]_NN ._. The_DT results_NNS suggest_VBP that_IN these_DT memory_NN cells_NNS appear_VBP
        to_TO have_VB undergone_VBN biased_VBN differentiation_NN into_IN Th_NNP 1_CD cells_NNS ,_,
        perhaps_RB as_IN a_DT result_NN of_IN signals_NNS received_VBD in_IN the_DT synovial_NN
        microenvironment_NN ._. The_DT small_JJ increase_NN in_IN the_DT number_NN of_IN
        IFN-γ-producing_NNP cells_NNS found_VBD in_IN rheumatoid_NN blood_NN may_MD well_RB
        reflect_VB the_DT recirculation_NN of_IN memory_NN T_NN cells_NNS previously_RB
        activated_VBN in_IN the_DT blood_NN [_NN 7_CD ,_, 23_CD ]_NN ._.
        Tm_NNP were_VBD used_VBN for_IN these_DT studies_NNS because_IN it_PRP has_VBZ been_VBN shown_VBN
        [_NN 7_CD ,_, 9_CD ]_NN that_IN the_DT majority_NN of_IN CD_NNP 4_CD +_NN cells_NNS in_IN the_DT RA_NNP synovium_NN
        are_VBP of_IN the_DT memory_NN subset_NN ._. Therefore_RB ,_, a_DT potential_JJ concern_NN
        was_VBD that_IN the_DT 
        in_IN vitro_NN priming_VBG protocol_NN might_MD
        select_VB for_IN cells_NNS that_WDT are_VBP already_RB committed_VBN to_TO IFN-γ_NNP or_CC
        IL-_NNP 4_CD production_NN ,_, rather_RB than_IN generate_VB new_JJ effector_NN cells_NNS ._.
        In_IN humans_NNS ,_, however_RB ,_, highly_RB polarized_VBN effector_NN T_NN cells_NNS arise_VBP
        late_RB in_IN the_DT differentiation_NN pathway_NN [_NN 17_CD ,_, 18_CD ,_, 19_CD ]_NN ._. Whereas_IN
        early_JJ memory_NN T_NN cells_NNS ,_, identified_VBN by_IN the_DT CD_NNP 45_CD RO_NNP +_NN ,_, CD_NNP 27_CD
        +_NN phenotype_NN ,_, have_VBP the_DT potential_NN to_TO secrete_NN IL-_NNP 2_CD and_CC IFN-γ_NNP ,_,
        these_DT cells_NNS cannot_NN produce_NN IL-_NNP 4_CD and_CC few_JJ produce_NN IFN-γ_NNP in_IN
        the_DT absence_NN of_IN IL-_NNP 2_CD [_NN 17_CD ,_, 19_CD ]_NN ._. Only_RB mature_VBP memory_NN cells_NNS ,_,
        identified_VBN by_IN the_DT presence_NN of_IN CD_NNP 45_CD RO_NNP and_CC the_DT loss_NN of_IN CD_NNP 27_CD
        cell-surface_JJ expression_NN ,_, have_VBP the_DT capacity_NN to_TO secrete_NN IFN-γ_NNP
        or_CC IL-_NNP 4_CD alone_RB ._. We_PRP have_VBP previously_RB shown_VBN that_IN the_DT 
        in_IN vitro_NN priming_VBG protocol_NN used_VBN in_IN the_DT
        present_JJ study_NN induces_VBZ the_DT differentiation_NN of_IN early_JJ
        uncommitted_JJ CD_NNP 4_CD +_NN ,_, CD_NNP 27_CD +_NN memory_NN T_NN cells_NNS into_IN IL-_NNP 4_CD -_: producing_VBG
        effector_NN cells_NNS [_NN 17_CD ]_NN ._. Thus_RB ,_, it_PRP was_VBD hypothesized_VBN that_IN the_DT
        uncommitted_JJ early_JJ CD_NNP 4_CD +_NN ,_, CD_NNP 27_CD +_NN memory_NN cells_NNS that_WDT were_VBD
        isolated_VBN from_IN the_DT RA_NNP synovium_NN or_CC blood_NN maintained_VBD the_DT
        capacity_NN to_TO differentiate_VB into_IN IL-_NNP 4_CD -_: producing_VBG effector_NN
        cells_NNS ._. The_DT majority_NN of_IN T_NN cells_NNS that_WDT are_VBP found_VBN in_IN the_DT RA_NNP
        synovium_NN belong_VB to_TO the_DT early_JJ memory_NN subset_NN [_NN 7_CD ]_NN ._. Therefore_RB ,_,
        the_DT defective_JJ generation_NN of_IN IL-_NNP 4_CD producers_NNS from_IN RA_NNP synovial_NN
        fluid_JJ under_IN conditions_NNS that_WDT induced_VBD IL-_NNP 4_CD -_: producing_VBG effector_NN
        cells_NNS from_IN blood_NN memory_NN T_NN cells_NNS suggested_VBD that_IN the_DT
        rheumatoid_NN microenviroment_NN played_VBD an_DT important_JJ role_NN in_IN
        selecting_VBG or_CC modifying_VBG the_DT precursor_NN effector_NN memory_NN
        population_NN ._.
        CD_NNP 28_CD is_VBZ expressed_VBN by_IN most_JJS human_JJ T_NN cells_NNS and_CC is_VBZ thought_VBN
        to_TO be_VB critical_JJ for_IN T-_NNP cell_NN differentiation_NN ._. CD_NNP 28_CD is_VBZ also_RB
        important_JJ during_IN T-_NNP cell_NN receptor-mediated_JJ activation_NN ,_, IL-_NNP 2_CD
        production_NN ,_, and_CC the_DT prevention_NN of_IN anergy_NN [_NN 24_CD ]_NN ._. Recent_JJ
        studies_NNS [_NN 25_CD ,_, 26_CD ,_, 27_CD ]_NN have_VBP indicated_VBN that_IN there_EX were_VBD
        increased_VBN numbers_NNS of_IN CD_NNP 4_CD +_NN ,_, CD_NNP 28_CD -_: T_NN cells_NNS in_IN the_DT periphery_NN
        and_CC synovium_NN of_IN RA_NNP patients_NNS ._. Therefore_RB ,_, the_DT lack_NN of_IN
        expression_NN of_IN CD_NNP 28_CD on_IN RA_NNP CD_NNP 4_CD +_NN T_NN cells_NNS represented_VBD a_DT
        potential_JJ explanation_NN for_IN the_DT abnormal_JJ memory_NN T-_NNP cell_NN
        differentiation_NN observed_VBD in_IN RA_NNP blood_NN and_CC tissue_NN and_CC the_DT
        deficiency_NN in_IN IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS from_IN the_DT
        synovial_NN fluid_JJ after_IN 
        in_IN vitro_NN priming_VBG ._. However_RB ,_, CD_NNP 4_CD +_NN ,_,
        CD_NNP 28_CD -_: cells_NNS are_VBP a_DT minor_JJ subset_NN of_IN T_NN cells_NNS ,_, representing_VBG
        less_JJR than_IN 3_CD %_NN of_IN peripheral_JJ CD_NNP 4_CD +_NN T_NN cells_NNS from_IN the_DT most_RBS
        chronically_RB active_JJ RA_NNP patients_NNS versus_CC less_JJR than_IN 1_CD %_NN from_IN
        healthy_JJ control_NN individuals_NNS [_NN 26_CD ]_NN ,_, and_CC are_VBP therefore_RB
        unlikely_JJ to_TO account_VB for_IN the_DT broad_JJ defect_NN in_IN memory_NN T-_NNP cell_NN
        differentiation_NN found_VBD here_RB ._. We_PRP have_VBP observed_VBN that_IN CD_NNP 4_CD +_NN ,_,
        CD_NNP 28_CD -_: cells_NNS in_IN the_DT periphery_NN represent_VBP a_DT unique_JJ subset_NN that_WDT
        is_VBZ restricted_VBN to_TO the_DT CD_NNP 4_CD +_NN ,_, CD_NNP 27_CD -_: population_NN (_( Davis_NNP L_NNP ,_,
        unpublished_JJ observation_NN )_) ._. As_IN noted_VBD above_IN ,_, although_IN there_EX
        were_VBD increased_VBN numbers_NNS of_IN well-differentiated_JJ CD_NNP 4_CD +_NN ,_, CD_NNP 27_CD
        -_: cells_NNS in_IN the_DT RA_NNP synovium_NN ,_, these_DT cells_NNS represented_VBD the_DT
        minority_NN of_IN Tm_NNP [_NN 7_CD ]_NN ._. Therefore_RB ,_, the_DT inability_NN to_TO modulate_VBP
        effector_NN cell_NN responses_NNS in_IN RASF_NNP samples_NNS could_MD not_RB be_VB
        explained_VBN by_IN the_DT absence_NN of_IN CD_NNP 28_CD ._. Moreover_RB ,_, RASF_NNP T_NN cells_NNS
        were_VBD capable_JJ of_IN cell_NN growth_NN in_IN response_NN to_TO anti-_NN CD_NNP 28_CD mAbs_NNS
        and_CC cytokines_NNS ._. This_DT finding_VBG is_VBZ in_IN agreement_NN with_IN previous_JJ
        studies_NNS [_NN 28_CD ]_NN demonstrating_VBG that_IN the_DT CD_NNP 28_CD signaling_VBG pathway_NN
        was_VBD intact_JJ in_IN RA_NNP synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS ._.
        The_DT present_JJ studies_NNS also_RB demonstrated_VBN that_DT synovial_NN
        fluid_JJ Tm_NNP lacked_VBD the_DT capacity_NN to_TO generate_VB IL-_NNP 4_CD -_: secreting_VBG
        effector_NN cells_NNS in_IN numbers_NNS similar_JJ to_TO those_DT found_VBD in_IN the_DT
        periphery_NN ._. Our_PRP$ previous_JJ studies_NNS [_NN 17_CD ]_NN demonstrated_VBN that_IN
        IL-_NNP 4_CD was_VBD required_VBN during_IN the_DT 
        in_IN vitro_NN priming_VBG cultures_NNS to_TO generate_VB
        IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS from_IN non-_NN IL-_NNP 4_CD -_: producing_VBG early_JJ
        memory_NN precursor_NN cells_NNS ._. Therefore_RB ,_, one_CD concern_NN in_IN the_DT
        current_JJ studies_NNS was_VBD that_IN RA_NNP T_NN cells_NNS might_MD require_VB exogenous_JJ
        IL-_NNP 4_CD to_TO generate_VB IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS ._.
        An_DT additional_JJ concern_NN was_VBD that_IN IFN-γ-producing_NNP effector_NN
        cells_NNS might_MD inhibit_VB potential_JJ IL-_NNP 4_CD precursors_NNS from_IN
        differentiating_VBG or_CC expanding_VBG in_IN these_DT cultures_NNS ,_, although_IN
        previous_JJ studies_NNS [_NN 29_CD ,_, 30_CD ,_, 31_CD ]_NN demonstrated_VBN that_IN IFN-γ_NNP
        indirectly_RB affected_VBD the_DT generation_NN of_IN IL-_NNP 4_CD -_: secreting_VBG cells_NNS
        through_IN the_DT activities_NNS of_IN antigen-presenting_JJ cells_NNS ._. It_PRP
        should_MD be_VB noted_VBN that_IN antigen-presenting_JJ cells_NNS were_VBD depleted_VBN
        from_IN the_DT memory_NN T-_NNP cell_NN population_NN before_IN priming_VBG in_IN the_DT
        present_JJ studies_NNS ,_, and_CC therefore_RB this_DT possibility_NN was_VBD only_RB a_DT
        minor_JJ concern_NN ._.
        Both_DT the_DT addition_NN of_IN IL-_NNP 4_CD to_TO the_DT priming_VBG cultures_NNS and_CC
        the_DT presence_NN of_IN anti-_NN IFN-γ_NNP antibody_NN ensured_JJ that_IN potential_JJ
        IL-_NNP 4_CD -_: secreting_VBG precursor_NN populations_NNS had_VBD optimal_NN conditions_NNS
        for_IN differentiation_NN ._. Blocking_NNP IFN-γ_NNP activity_NN during_IN 
        in_IN vitro_NN priming_VBG with_IN a_DT neutralizing_VBG
        anti-_NN IFN-γ_NNP antibody_NN had_VBD little_JJ effect_NN on_IN the_DT number_NN of_IN
        IFN-γ-secreting_NNP effector_NN cells_NNS detected_VBD on_IN subsequent_JJ
        restimulation_NN ._. Moreover_RB ,_, the_DT availability_NN of_IN IFN-γ_NNP had_VBD
        little_JJ impact_NN on_IN the_DT generation_NN of_IN either_DT subset_NN ._. Thus_RB ,_, the_DT
        inability_NN to_TO generate_VB IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS from_IN
        RASF_NNP precursor_NN cells_NNS was_VBD not_RB simply_RB explained_VBN by_IN the_DT
        presence_NN of_IN IFN-γ-producing_NNP effector_NN cells_NNS or_CC the_DT lack_NN of_IN a_DT
        subset_NN of_IN fully_RB differentiated_JJ IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS in_IN
        the_DT initial_JJ memory_NN cell_NN population_NN ._. Recent_JJ studies_NNS [_NN 32_CD ]_NN
        have_VBP suggested_VBN that_IN there_EX is_VBZ an_DT intrinsic_JJ defect_NN in_IN the_DT
        development_NN of_IN IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS in_IN RA_NNP
        patients_NNS ._. Therefore_RB ,_, it_PRP is_VBZ possible_JJ that_IN the_DT apparent_JJ
        disordered_JJ differentiation_NN of_IN effector_NN cells_NNS becomes_VBZ more_JJR
        marked_VBN at_IN inflammatory_JJ sites_NNS such_JJ as_IN in_IN the_DT rheumatoid_NN
        synovium_NN [_NN 23_CD ,_, 32_CD ]_NN ._.
        It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN both_DT IL-_NNP 2_CD production_NN and_CC
        IL-_NNP 4_CD production_NN appear_VBP to_TO be_VB downregulated_JJ in_IN RASF_NNP T_NN cells_NNS ._.
        Previous_JJ studies_NNS [_NN 9_CD ]_NN have_VBP shown_VBN that_WDT mature_VBP memory_NN (_( CD_NNP 45_CD RO_NNP
        +_NN ,_, CD_NNP 27_CD -_: )_) CD_NNP 4_CD +_NN T_NN cells_NNS isolated_VBN from_IN the_DT blood_NN have_VBP the_DT
        same_JJ capacity_NN as_IN early_JJ memory_NN (_( CD_NNP 45_CD RO_NNP +_NN ,_, CD_NNP 27_CD +_NN )_) CD_NNP 4_CD +_NN T_NN
        cells_NNS to_TO produce_VB IL-_NNP 2_CD ._. In_IN the_DT RA_NNP synovium_NN ,_, IL-_NNP 2_CD appears_VBZ to_TO
        be_VB downregulated_JJ [_NN 9_CD ]_NN ._. It_PRP should_MD be_VB noted_VBN that_IN IL-_NNP 2_CD
        production_NN was_VBD not_RB decreased_VBN in_IN T_NN cells_NNS obtained_VBN from_IN
        osteoarthritic_JJ joints_NNS [_NN 9_CD ]_NN ._. In_IN addition_NN ,_, Tm_NNP obtained_VBD from_IN
        other_JJ tissues_NNS ,_, such_JJ as_IN inflamed_JJ tonsil_NN ,_, expressed_VBD levels_NNS of_IN
        IL-_NNP 2_CD that_WDT were_VBD similar_JJ to_TO those_DT in_IN blood_NN (_( Davis_NNP L_NNP ,_,
        unpublished_JJ observation_NN )_) ._. Therefore_RB ,_, migration_NN into_IN tissue_NN 
        per_IN se_FW does_VBZ not_RB induce_VB downregulation_NN
        of_IN IL-_NNP 2_CD production_NN ._. Recent_JJ studies_NNS [_NN 33_CD ]_NN have_VBP attributed_VBN
        the_DT lack_NN of_IN IL-_NNP 2_CD production_NN by_IN synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS to_TO a_DT
        defect_NN in_IN the_DT T-_NNP cell_NN receptor-mediated_JJ signal_NN transduction_NN
        cascade_NN ._. However_RB ,_, in_IN the_DT present_JJ studies_NNS we_PRP made_VBD use_NN of_IN
        stimuli_NNS that_IN bypassed_JJ the_DT early_JJ steps_NNS in_IN the_DT T-_NNP cell_NN
        receptor-mediated_JJ signaling_VBG cascade_NN and_CC found_VBD that_IN there_EX
        was_VBD defective_JJ IL-_NNP 2_CD production_NN in_IN cells_NNS stimulated_VBN
        immediately_RB on_IN isolation_NN from_IN the_DT RA_NNP synovium_NN ,_, whereas_IN
        these_DT same_JJ cells_NNS were_VBD completely_RB competent_JJ for_IN IFN-γ_NNP
        production_NN ._. Thus_RB ,_, it_PRP is_VBZ interesting_JJ to_TO speculate_VB that_IN IL-_NNP 2_CD
        and_CC IL-_NNP 4_CD are_VBP downregulated_JJ in_IN the_DT rheumatoid_NN synovium_NN by_IN
        some_DT active_JJ repressor_NN mechanism_NN induced_VBN by_IN the_DT synovial_NN
        microenvironment_NN ._. Although_IN recent_JJ studies_NNS have_VBP indicated_VBN
        that_DT redox_NN balance_NN alterations_NNS were_VBD critical_JJ in_IN determining_VBG
        whether_IN cells_NNS can_MD produce_VB IL-_NNP 2_CD [_NN 33_CD ,_, 34_CD ]_NN ,_, it_PRP is_VBZ not_RB known_VBN
        whether_IN this_DT influences_VBZ IL-_NNP 4_CD production_NN ,_, or_CC has_VBZ it_PRP been_VBN
        determined_VBN whether_IN readjustment_NN of_IN redox_NN balance_NN in_IN RA_NNP
        synovial_NN T_NN cells_NNS could_MD correct_VB the_DT deficiency_NN in_IN IL-_NNP 4_CD ._.
        Few_JJ studies_NNS have_VBP used_VBN similar_JJ techniques_NNS to_TO assess_VB
        cytokine_NN production_NN in_IN blood_NN ,_, synovial_NN tissue_NN ,_, and_CC synovial_NN
        fluid_JJ obtained_VBN from_IN RA_NNP patients_NNS ._. Immunohistology_NNP is_VBZ
        routinely_RB carried_VBN out_IN on_IN synovial_NN tissue_NN sections_NNS ,_, whereas_IN
        enzyme-linked_JJ immunosorbent_NN assays_NNS are_VBP employed_VBN to_TO
        determine_VB cytokine_NN profiles_NNS of_IN serum_NN and_CC synovial_NN fluid_JJ [_NN
        9_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 31_CD ]_NN ._. Therefore_RB ,_, it_PRP has_VBZ remained_VBN difficult_JJ to_TO
        determine_VB the_DT potential_JJ impact_NN of_IN these_DT compartments_NNS on_IN
        T-_NNP cell_NN function_NN in_IN rheumatoid_NN inflammation_NN ._. In_IN the_DT current_JJ
        studies_NNS ,_, RA_NNP T_NN cells_NNS from_IN all_DT three_CD compartments_NNS produced_VBN
        increased_VBN amounts_NNS of_IN IFN-γ_NNP on_IN immediate_JJ stimulation_NN ._.
        However_RB ,_, the_DT cytokine_NN profiles_NNS diverged_JJ when_WRB assessed_VBN after_IN
        
        in_IN vitro_NN priming_VBG ._. Whereas_IN ,_, synovial_NN
        tissue_NN Tm_NNP were_VBD deficient_NN in_IN IL-_NNP 4_CD producers_NNS compared_VBN with_IN
        matching_VBG blood_NN ,_, these_DT cells_NNS retained_VBD the_DT ability_NN to_TO
        generate_VB IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS ._. In_IN this_DT regard_NN ,_,
        recent_JJ studies_NNS [_NN 31_CD ]_NN have_VBP suggested_VBN that_DT synovial_NN tissue_NN
        cells_NNS were_VBD selectively_RB responsive_JJ to_TO IL-_NNP 12_CD produced_VBN in_IN the_DT
        synovium_NN ,_, because_IN IL-_NNP 12_CD induced_VBN increased_VBN production_NN of_IN
        IFN-γ_NNP ,_, but_CC not_RB IL-_NNP 2_CD and_CC IL-_NNP 4_CD ._. Those_DT studies_NNS support_VBP the_DT
        hypothesis_NNS that_IN the_DT synovial_NN microenvironment_NN may_MD play_VB a_DT
        role_NN in_IN skewing_VBG T_NN cells_NNS toward_IN a_DT Th_NNP 1_CD phenotype_NN ._. The_DT finding_VBG
        that_IN IL-_NNP 4_CD -_: producing_VBG effector_NN cells_NNS could_MD be_VB generated_VBN from_IN
        synovial_NN tissue_NN T_NN cells_NNS once_RB removed_VBN from_IN that_DT environment_NN
        suggests_VBZ that_IN all_DT of_IN the_DT cells_NNS were_VBD not_RB yet_RB terminally_RB
        polarized_VBN to_TO Th_NNP 1_CD -_: like_IN effector_NN cells_NNS ._. Importantly_NNP ,_, synovial_NN
        fluid_JJ T_NN cells_NNS appeared_VBD to_TO have_VB been_VBN more_RBR affected_JJ by_IN the_DT
        synovial_NN microenvironment_NN than_IN synovial_NN tissue_NN T_NN cells_NNS
        because_IN ,_, regardless_RB of_IN the_DT 
        in_IN vitro_NN priming_VBG conditions_NNS ,_, these_DT
        cells_NNS yielded_VBD increased_VBN percentages_NNS of_IN IFN-γ_NNP producers_NNS and_CC
        were_VBD deficient_NN in_IN IL-_NNP 4_CD producers_NNS ._.
        The_DT present_JJ data_NN suggest_VBP that_DT synovial_NN fluid_JJ T_NN cells_NNS are_VBP
        those_DT that_WDT have_VBP passed_VBN through_IN the_DT synovium_NN ,_, whereas_IN
        synovial_NN tissue_NN T_NN cells_NNS are_VBP a_DT mixed_JJ population_NN of_IN recently_RB
        migrated_JJ cells_NNS and_CC those_DT that_WDT have_VBP been_VBN retained_VBN in_IN the_DT
        synovium_NN ._. Whether_IN the_DT inability_NN of_IN synovial_NN fluid_JJ memory_NN T_NN
        cells_NNS to_TO generate_VB IL-_NNP 4_CD producers_NNS is_VBZ the_DT result_NN of_IN
        activation_NN ,_, differentiation_NN ,_, or_CC prolonged_JJ exposure_NN to_TO the_DT
        synovial_NN microenvironment_NN ,_, the_DT data_NNS clearly_RB indicate_VBP that_IN a_DT
        majority_NN of_IN synovial_NN fluid_JJ memory_NN T_NN cells_NNS appear_VBP to_TO be_VB
        polarized_VBN IFN-γ_NNP effector_NN cells_NNS ._.
        In_IN summary_NN ,_, the_DT present_JJ studies_NNS show_VBP that_IN RA_NNP blood_NN and_CC
        synovial_NN T_NN cells_NNS contain_VBP increased_VBN numbers_NNS of_IN polarized_VBN
        IFN-γ_NNP effector_NN cells_NNS ._. RA_NNP synovial_NN T_NN cells_NNS also_RB demonstrated_VBD
        a_DT deficiency_NN in_IN the_DT ability_NN to_TO generate_VB IL-_NNP 4_CD -_: producing_VBG
        effector_NN cells_NNS ._. The_DT diminished_VBN ability_NN to_TO generate_VB IL-_NNP 4_CD
        effector_NN cells_NNS from_IN synovial_NN T_NN cells_NNS 
        in_IN vitro_NN suggests_VBZ that_IN the_DT rheumatoid_NN
        microenvironment_NN alters_NNS T-_NNP cell_NN effector_NN function_NN and_CC
        thereby_RB perpetuates_VBZ the_DT chronic_JJ inflammatory_JJ disease_NN
        state_NN ._.
      
    
  
